status

Sonata Software Achieves AWS Premier Tier Status in the AWS Partner Network

BANGALORE, India, Feb. 10, 2026 /PRNewswire/ -- Sonata Software (NSE: SONATSOFTW) (BSE: 532221), a leading AI-first Modernization Engineering company, today…

2 weeks ago

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors

PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR…

2 weeks ago

Nexalin Technology Receives Nasdaq Listing Status Notification

HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in…

1 month ago

Sharjah Achieves Historic WHO Age-Friendly Status

SHARJAH, UAE, Jan. 19, 2026 /PRNewswire/ -- The Emirate of Sharjah, UAE, has reached a new global milestone by obtaining…

1 month ago

GH Research to Announce IND Status for GH001

DUBLIN, Jan. 02, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the…

2 months ago

Alvotech Provides Update on the Status ofU.S. Biologics License Application for AVT05

REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…

4 months ago

Mactores Earns AWS Healthcare Competency Status, Enabling HIPAA-Compliant AI Solutions for Improved Patient Outcomes and Operational Excellence

Mactores has earned AWS Healthcare Competency, validating its expertise in automation-first, HIPAA-compliant solutions. By modernizing data foundations and accelerating AI…

5 months ago

Trianz Achieves AWS Premier Tier Status in the Amazon Web Services Partner Network

SANTA CLARA, Calif., Sept. 4, 2025 /PRNewswire/ -- Trianz, a digital transformation software and solutions company, announced today that it…

6 months ago

NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

6 months ago

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from…

6 months ago